Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CTVNASDAQ:DHNASDAQ:MTLSNASDAQ:YXT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTVInnovid$3.14$3.14$1.56▼$3.40$466.21M3.251.31 million shsN/ADHDefinitive Healthcare$4.05+0.6%$3.42$2.15▼$6.16$597.55M1.64803,537 shs237,669 shsMTLSMaterialise$5.74+2.3%$5.41$3.93▼$9.69N/A1.58185,788 shs60,526 shsYXTYXT.COM Group$0.88-0.5%$0.85$0.47▼$11.00$53.14MN/A61,839 shs40,939 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTVInnovid0.00%0.00%0.00%0.00%+81.50%DHDefinitive Healthcare+0.62%+6.73%+15.90%+61.16%-24.39%MTLSMaterialise+2.32%+3.42%+7.09%+37.32%+21.48%YXTYXT.COM Group-0.52%-7.95%+2.33%-0.45%+87,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTVInnovid0.1718 of 5 stars1.00.00.00.01.40.00.6DHDefinitive Healthcare1.3651 of 5 stars3.01.00.00.00.02.50.6MTLSMaterialise0.3187 of 5 stars0.04.00.00.00.00.00.6YXTYXT.COM GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTVInnovid 2.00Hold$2.75-12.42% DownsideDHDefinitive Healthcare 1.90Reduce$5.1026.08% UpsideMTLSMaterialise 0.00N/AN/AN/AYXTYXT.COM Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest YXT, CTV, DH, and MTLS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2025DHDefinitive HealthcareThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.00 ➝ $3.405/9/2025DHDefinitive HealthcareBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTVInnovid$151.56M3.08$0.05 per share62.93$1.39 per share2.26DHDefinitive Healthcare$247.91M2.43$5.32 per share0.76$4.09 per share0.99MTLSMaterialise$288.70MN/A$0.54 per share10.63$4.55 per shareN/AYXTYXT.COM Group$45.37M1.17N/AN/A$0.52 per share1.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTVInnovid-$31.91M-$0.09N/A78.50N/A-9.09%-7.08%-5.70%N/ADHDefinitive Healthcare-$413.12M-$4.39N/A28.897.00-206.05%3.69%2.15%8/4/2025 (Estimated)MTLSMaterialise$14.54M$0.1733.77∞N/A3.45%3.77%2.35%7/30/2025 (Estimated)YXTYXT.COM Group-$12.57MN/A0.00∞N/AN/AN/AN/AN/ALatest YXT, CTV, DH, and MTLS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025DHDefinitive Healthcare$0.02$0.05+$0.03-$0.95$56.20 million$59.19 million4/24/2025Q1 2025MTLSMaterialise$0.02-$0.01-$0.03-$0.01$67.00 million$71.79 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTVInnovidN/AN/AN/AN/AN/ADHDefinitive HealthcareN/AN/AN/AN/AN/AMTLSMaterialiseN/AN/AN/AN/AN/AYXTYXT.COM GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTVInnovidN/A3.523.52DHDefinitive Healthcare0.371.751.75MTLSMaterialise0.081.881.72YXTYXT.COM Group0.551.21N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTVInnovid25.46%DHDefinitive Healthcare98.67%MTLSMaterialise19.30%YXTYXT.COM GroupN/AInsider OwnershipCompanyInsider OwnershipCTVInnovid9.50%DHDefinitive Healthcare16.28%MTLSMaterialise1.23%YXTYXT.COM GroupN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTVInnovid2,280148.47 million134.37 millionNot OptionableDHDefinitive Healthcare970148.64 million124.44 millionNot OptionableMTLSMaterialise2,514N/AN/AOptionableYXTYXT.COM Group74460.08 millionN/AN/AYXT, CTV, DH, and MTLS HeadlinesRecent News About These CompaniesYXT.com announces CFO resignation and new executive appointmentsJuly 2 at 6:45 AM | uk.investing.comYXT.com Group Holding Limited Announces Resignation of CFO and Appointment of New Director and CFO - NasdaqJuly 2 at 6:45 AM | nasdaq.comYXT.com Announces Changes in Board of Directors and ManagementJune 30, 2025 | globenewswire.comYXT.COM Group (NASDAQ:YXT) Trading Down 2.2% - Here's WhyJune 26, 2025 | marketbeat.comYXT YXT.COM Group Holding LimitedJune 14, 2025 | seekingalpha.comYXT.com's AI Learning Platform Deployed by Siemens for Digital Workforce TransformationJune 9, 2025 | globenewswire.comZooming In On YXT.COM Group Holding's EarningsMay 4, 2025 | finance.yahoo.comYXT.com Filed 2024 Annual Report on Form 20-FApril 24, 2025 | globenewswire.comEQS-News: YXT.com Cuts Loss By 59.9% In 2024 With AI, Approves $10M Share Repurchase ProgramApril 8, 2025 | markets.businessinsider.comYXT.com rebrands as ‘Radnova’April 2, 2025 | markets.businessinsider.comYXT.com Rebrands as Radnova and Launches AI-Enabled Enterprise Productivity SolutionsApril 2, 2025 | globenewswire.comYXT.com Reports 2024 Financial Results and Strategic ShiftMarch 27, 2025 | tipranks.comYXT.com Reports Full Year 2024 Unaudited Financial ResultsMarch 27, 2025 | globenewswire.comYXT.com Group Holding Limited to Announce Full Year 2024 Financial Results on March 27, 2025March 21, 2025 | globenewswire.comEQS-News: Digital Learning Taking Off: Insights From Digital Enterprise Learning Solutions Provider YXT.com's 2024-2025 Enterprise Learning ReportMarch 4, 2025 | markets.businessinsider.comYXT.com Implements Enterprise-Wide Learning Solution for Fortune 500 Infrastructure Leader, Advancing Digital TransformationJanuary 7, 2025 | globenewswire.comYXT.COM GROUP HOLDING LIMITED: YXT.com Announces Strategic Management ChangesDecember 24, 2024 | finanznachrichten.deYXT.com Drives Digital Transformation for Leading Chinese Automotive BrandDecember 17, 2024 | markets.businessinsider.comYXT.com Reports Improved Margins Amid Revenue DeclineDecember 13, 2024 | tipranks.comYXT.com Chief Resigns; Founder Takes HelmNovember 27, 2024 | marketwatch.comYXT.com Group Holding Limited Reports Financial Results for First Nine Months of 2024November 26, 2024 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeSoundHound’s AI Growth Story Is Just Getting StartedBy Gabriel Osorio-Mazilli | June 16, 2025View SoundHound’s AI Growth Story Is Just Getting StartedUnitedHealth Stock Dips: Is This a Value Buy Opportunity?By Jeffrey Neal Johnson | June 13, 2025View UnitedHealth Stock Dips: Is This a Value Buy Opportunity?3 Summer Short-Squeeze Candidates With Catalysts for CoveringBy Thomas Hughes | June 30, 2025View 3 Summer Short-Squeeze Candidates With Catalysts for CoveringYXT, CTV, DH, and MTLS Company DescriptionsInnovid NYSE:CTV$3.14 0.00 (0.00%) As of 02/21/2025Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. The company serves consumer packaged goods, pharmaceutical and healthcare, retail, financial services, and automotive and technology industries; third party agencies; and publishers in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Innovid Corp. was incorporated in 2007 and is headquartered in New York, New York.Definitive Healthcare NASDAQ:DH$4.04 +0.03 (+0.62%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.Materialise NASDAQ:MTLS$5.74 +0.13 (+2.32%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.YXT.COM Group NASDAQ:YXT$0.88 0.00 (-0.52%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.YXT.COM Group Holding Limited, through its subsidiaries, provides digital corporate learning solution in the People's Republic of China. The company offers corporate learning platform, personalized e-learning system, teaching tools, and online courses, as well as offline courses and courseware recording service. It also engages in the technology development; and sale of Software-as-a-Service and content. YXT.COM Group Holding Limited was formerly known as Unicentury Group Holding Limited and changed its name to YXT.COM Group Holding Limited in May 2021. The company was founded in 2011 and is based in Suzhou, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
